Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. III. AB-100 (NSC-37095).
D000970:Antineoplastic Agents / Q000628:therapy*; D064987:Cell- and Tissue-Based Therapy; D009101:Multiple Myeloma / Q000628:therapy*; D010949:Plasma; D010950:Plasma Cells
D000970:Antineoplastic Agents
ANTINEOPLASTIC AGENTS/therapy; MYELOMA, PLASMA CELL/therapy